GlassScriptPhysician profile
Tiffany C Schaefer
NPI 1568880896
$1,805.30
in general payments reported to CMS, 2019-2025
13 companies · $392 in 2025
The $392 reported for 2025 was more than what 76% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $508 · 2023: $271 · 2024: $634 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,297.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $288.25 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Procuity |
| Tactile Systems Technology INC | $252.65 | 2023 | Entre Plus, Flexitouch Plus |
| Vertex Pharmaceuticals Incorporated | $245.15 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $232.13 | 2021 | |
| Novo Nordisk INC | $149.62 | 2021-2024 | Wegovy |
| Baxter Healthcare | $127.15 | 2024 | Starling System |
| Molnlycke Health Care US, LLC | $123.28 | 2024 | Mepilex Border Sacrum, Mepilex Border Post-Op Ag, Mepilex Border Flex |
| Solventum Corporation | $117.60 | 2024 | V.A.C. Dermatac, V.A.C. Veraflo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.31 | 2021 | |
| Gilead Sciences, INC. | $60.07 | 2021 | |
| Alexion Pharmaceuticals, INC. | $57.79 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.59 | 2024 | Lifevest |
| Lantheus Medical Imaging, INC. | $18.71 | 2023 | Definity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.